{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:11:27Z","timestamp":1790485887841,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology, Government of West Bengal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.hbpd.2020.03.010","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:07:00Z","timestamp":1586304420000},"page":"205-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions"],"prefix":"10.1016","volume":"19","author":[{"given":"Akash","family":"Bararia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriyo","family":"Ghatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibajyoti","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilabja","family":"Sikdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2020.03.010_bib0001","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1101\/gad.275776.115","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"30","author":"Ying","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0002","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1389202919666180221160753","article-title":"Genetic alterations of periampullary and pancreatic ductal adenocarcinoma: an overview","volume":"19","author":"Sikdar","year":"2018","journal-title":"Curr Genom"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0003","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"20","author":"Hezel","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12262-015-1365-x","article-title":"Epidemiology of pancreatic and periampullary cancer","volume":"77","author":"Thapa","year":"2015","journal-title":"Indian J Surg"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijc.10446","article-title":"Cancer patterns in eastern India: the first report of the Kolkata cancer registry","volume":"100","author":"Sen","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.pap.0000155055.14238.25","article-title":"Precursors to invasive pancreatic cancer","volume":"12","author":"Maitra","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0007","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000123838","article-title":"Pancreatic carcinogenesis","volume":"8","author":"Koorstra","year":"2008","journal-title":"Pancreatology"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0008","first-page":"1583","article-title":"Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer","volume":"26","author":"Antwi","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0009","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/mc.20779","article-title":"Occupational risk factors and pancreatic cancer: a review of recent findings","volume":"51","author":"Andreotti","year":"2012","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mc.20786","article-title":"Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer","volume":"51","author":"Duell","year":"2012","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0011","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/j.1572-0241.2007.01510.x","article-title":"Risk factors for pancreatic cancer: case-control study","volume":"102","author":"Hassan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0012","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00534-005-1056-2","article-title":"Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas","volume":"13","author":"Sato","year":"2006","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0013","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc949","article-title":"Pancreatic cancer biology and genetics","volume":"2","author":"Bardeesy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0014","doi-asserted-by":"crossref","first-page":"716","DOI":"10.5858\/2010-0566-RA.1","article-title":"Molecular signatures of pancreatic cancer","volume":"135","author":"Hong","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13238-014-0031-6","article-title":"Driver mutations of cancer epigenomes","volume":"5","author":"Roy","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0016","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2217\/epi-2015-0016","article-title":"The promise of epigenomic therapeutics in pancreatic cancer","volume":"8","author":"Lomberk","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0017","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg816","article-title":"The fundamental role of epigenetic events in cancer","volume":"3","author":"Jones","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0018","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0019","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nm.2305","article-title":"Cancer epigenetics reaches mainstream oncology","volume":"17","author":"Rodr\u00edguez-Paredes","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0020","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrc1507","article-title":"CpG island methylator phenotype in cancer","volume":"4","author":"Issa","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0021","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-0004.2011.01809.x","article-title":"Epigenetic modifications in cancer","volume":"81","author":"Kanwal","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3410\/B3-9","article-title":"Epigenetic changes in cancer","volume":"3","author":"Esteller","year":"2011","journal-title":"F1000 Biol Rep"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0023","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1045","article-title":"The power and the promise of DNA methylation markers","volume":"3","author":"Laird","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0024","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s005340070005","article-title":"Precancerous conditions of pancreatic carcinoma","volume":"7","author":"L\u00fcttges","year":"2000","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/474905","article-title":"Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN","volume":"2014","author":"Distler","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0026","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/modpathol.3800991","article-title":"CpG island methylation profile of pancreatic intraepithelial neoplasia","volume":"21","author":"Sato","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0027","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0002-9440(10)61104-2","article-title":"Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma","volume":"160","author":"Fukushima","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0028","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2012.03.022","article-title":"Road to early detection of pancreatic cancer: attempts to utilize epigenetic biomarkers","volume":"342","author":"Fukushige","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0029","first-page":"2847","article-title":"CpG island methylation in premalignant stages of gastric carcinoma","volume":"61","author":"Kang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0030","first-page":"4740","article-title":"Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression","volume":"58","author":"Wilentz","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0031","first-page":"1835","article-title":"Hypermethylation of multiple genes in pancreatic adenocarcinoma","volume":"60","author":"Ueki","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0032","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4161\/cbt.84","article-title":"Aberrant methylation of the 5\u2032 CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanINs","volume":"1","author":"Jansen","year":"2002","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0033","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00534-005-1057-1","article-title":"The role of epigenetic alterations in pancreatic cancer","volume":"13","author":"Sato","year":"2006","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0034","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/gast.2002.34160","article-title":"Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas","volume":"123","author":"Sato","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/5947","article-title":"Cancer epigenetics comes of age","volume":"21","author":"Jones","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0036","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","article-title":"DNA hypermethylation in tumorigenesis: epigenetics joins genetics","volume":"16","author":"Baylin","year":"2000","journal-title":"Trends Genet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0037","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.gastro.2005.11.008","article-title":"Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers","volume":"130","author":"Sato","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0038","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0002-9440(10)63053-2","article-title":"STK11\/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas","volume":"159","author":"Sato","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0039","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/modpathol.2008.157","article-title":"Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas","volume":"21","author":"Hong","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/sj.onc.1208050","article-title":"Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma","volume":"24","author":"Sato","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0041","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4161\/cbt.4.7.1802","article-title":"Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms","volume":"4","author":"Martin","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0042","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.MP.0000094088.37888.A6","article-title":"Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas","volume":"16","author":"Kim","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0043","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/cncr.24893","article-title":"Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis","volume":"116","author":"Liggett","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0044","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2013.08.015","article-title":"Chronic pancreatitis: a path to pancreatic cancer","volume":"345","author":"Pinho","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0045","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1158\/0008-5472.CAN-05-2664","article-title":"DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease","volume":"66","author":"Matsubayashi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0046","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4419-9967-2_2","article-title":"DNA hypomethylation and hemimethylation in cancer","volume":"754","author":"Ehrlich","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0047","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0048","first-page":"8540","article-title":"Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma","volume":"61","author":"Ueki","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0049","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9440(10)64347-7","article-title":"Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation","volume":"160","author":"Rosty","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00595-004-2858-6","article-title":"Role of hypermethylation on carcinogenesis in the pancreas","volume":"34","author":"Kuroki","year":"2004","journal-title":"Surg Today"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0051","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MPA.0b013e318223d1a5","article-title":"Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features","volume":"41","author":"Zhao","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0052","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4161\/cbt.7.7.6208","article-title":"Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma","volume":"7","author":"Omura","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0053","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molonc.2009.03.004","article-title":"Characterizing DNA methylation patterns in pancreatic cancer genome","volume":"3","author":"Tan","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0054","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/00365521.2017.1301989","article-title":"Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma","volume":"52","author":"Syren","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10038-005-0235-y","article-title":"Abrogation of DUSP6 by hypermethylation in human pancreatic cancer","volume":"50","author":"Xu","year":"2005","journal-title":"J Hum Genet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0056","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4161\/cbt.4.1.1378","article-title":"The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer","volume":"4","author":"Sato","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0057","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1158\/1078-0432.CCR-12-3224","article-title":"Novel methylation biomarker panel for the early detection of pancreatic cancer","volume":"19","author":"Yi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0058","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1038\/sj.onc.1207783","article-title":"Identification of 27 5\u2032 CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers","volume":"23","author":"Hagihara","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0059","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/ijc.28765","article-title":"Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling","volume":"135","author":"Nones","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0060","first-page":"575","article-title":"Pancreatic cancer, a Mis-interpreter of the epigenetic language","volume":"89","author":"Iguchi","year":"2016","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0061","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1242\/dev.132829","article-title":"Slit-Robo signaling","volume":"143","author":"Blockus","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0062","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drudis.2014.09.008","article-title":"Slit\/Robo pathway: a promising therapeutic target for cancer","volume":"20","author":"Gara","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0063","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/301825","article-title":"A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?","volume":"62","author":"van der Put","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0064","first-page":"310","article-title":"Epigenetics and epigenetic alterations in pancreatic cancer","volume":"2","author":"Omura","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0065","first-page":"4158","article-title":"Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma","volume":"63","author":"Sato","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0066","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s004320100235","article-title":"Induction and expression of cyclin D3 in human pancreatic cancer","volume":"127","author":"Ebert","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0067","first-page":"1634","article-title":"Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis","volume":"57","author":"Gansauge","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0068","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1053\/gast.2002.36018","article-title":"Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas","volume":"123","author":"Kim","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0069","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1007\/s12032-010-9683-0","article-title":"The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma","volume":"28","author":"Zhu","year":"2011","journal-title":"Med Oncol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0070","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1158\/1078-0432.CCR-10-3431","article-title":"Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma","volume":"17","author":"Vincent","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0071","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/carcin\/bgi361","article-title":"DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas","volume":"27","author":"Peng","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0072","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/138920211794520132","article-title":"Genetic and epigenetic alterations in pancreatic carcinogenesis","volume":"12","author":"Delpu","year":"2011","journal-title":"Curr Genomics"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0073","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13148-016-0286-2","article-title":"Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma","volume":"8","author":"Henriksen","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0074","doi-asserted-by":"crossref","first-page":"E667","DOI":"10.3390\/ijms18030667","article-title":"Novel diagnostic and predictive biomarkers in pancreatic adenocarcinoma","volume":"18","author":"Chang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000380784","article-title":"Epigenetic biomarkers for the early detection of gastrointestinal cancer","volume":"1","author":"Chen","year":"2014","journal-title":"Gastrointest Tumors"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0076","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrg.2016.13","article-title":"Epigenetic modulators, modifiers and mediators in cancer aetiology and progression","volume":"17","author":"Feinberg","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0077","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ajg.2016.297","article-title":"Endoscopic pancreas fluid collection: methods and relevance for clinical care and translational science","volume":"111","author":"Hart","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0078","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.mpa.0000246665.68869.d4","article-title":"K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking","volume":"34","author":"Jiao","year":"2007","journal-title":"Pancreas"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0079","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/MPA.0000000000000487","article-title":"DNA hypermethylation as a blood-based marker for pancreatic cancer: a literature review","volume":"44","author":"Henriksen","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1349-7006.2006.00297.x","article-title":"Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4","volume":"97","author":"Takehara","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0081","doi-asserted-by":"crossref","first-page":"42553","DOI":"10.18632\/oncotarget.9924","article-title":"Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas","volume":"7","author":"Yokoyama","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0082","doi-asserted-by":"crossref","first-page":"e93760","DOI":"10.1371\/journal.pone.0093760","article-title":"Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice","volume":"9","author":"Yokoyama","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0083","doi-asserted-by":"crossref","first-page":"e18223","DOI":"10.1371\/journal.pone.0018223","article-title":"Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls","volume":"6","author":"Pedersen","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0084","doi-asserted-by":"crossref","first-page":"e37509","DOI":"10.1371\/journal.pone.0037509","article-title":"Whole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot study","volume":"7","author":"Dauksa","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/145749691210100108","article-title":"Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer","volume":"101","author":"Park","year":"2012","journal-title":"Scand J Surg"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0086","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fgene.2018.00108","article-title":"Identification and validation of a diagnostic and prognostic multi-gene biomarker panel for pancreatic ductal adenocarcinoma","volume":"9","author":"Klett","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0087","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3109\/13693786.2013.824623","article-title":"Expression of SAP5 and SAP9 in Candida albicans biofilms: comparison of bloodstream isolates with isolates from other sources","volume":"51","author":"Joo","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0088","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1499-3872(11)60014-3","article-title":"Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines","volume":"10","author":"Cai","year":"2011","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0089","first-page":"3735","article-title":"Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays","volume":"63","author":"Sato","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0090","first-page":"4487","article-title":"Identification of pancreatic cancer in biliary obstruction patients by fry site-specific methylation","volume":"17","author":"Angsuwatcharakon","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0091","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3892\/ol.2015.3241","article-title":"GSH2 promoter methylation in pancreatic cancer analyzed by quantitative methylation-specific polymerase chain reaction","volume":"10","author":"Gao","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0092","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13148-015-0139-4","article-title":"Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer","volume":"7","author":"Bauden","year":"2015","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0093","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1158\/0008-5472.CAN-09-4227","article-title":"Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a\/200b in association with elevated circulating miR-200a and miR-200b levels","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0094","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1158\/1055-9965.EPI-08-0630","article-title":"Genetic and epigenetic alterations of familial pancreatic cancers","volume":"17","author":"Brune","year":"2008","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0095","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1002\/cncr.26558","article-title":"Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates","volume":"118","author":"Kisiel","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0096","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3748\/wjg.v19.i11.1718","article-title":"Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids","volume":"19","author":"Kato","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0097","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.onc.1207269","article-title":"Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling","volume":"23","author":"Sato","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0098","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","article-title":"Pancreatic cancer","volume":"3","author":"Maitra","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0099","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/carcin\/bgr105","article-title":"Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development","volume":"32","author":"Zhang","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.hbpd.2020.03.010_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128814","article-title":"Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes","volume":"10","author":"Thompson","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220300710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220300710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:41:41Z","timestamp":1761493301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387220300710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1499387220300710"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.03.010","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}